Disparities in melanoma incidence and mortality in South-Eastern Europe: Increasing incidence and divergent mortality patterns. Is progress around the corner?

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Jelena BarbaricAriana Znaor

Abstract

Most countries in South-Eastern Europe (SEE) have lower incidence, but higher mortality rates of malignant melanoma (MM) of the skin compared to North-Western Europe (NWE). We explored trends in MM incidence and mortality in SEE countries by sex and age and compared them with the trends in NWE. We obtained data on incident cases and deaths from MM (ICD-10 code C43) from 11 population-based cancer registries in Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Malta, Romania, Serbia, Slovakia, Slovenia and Turkey. We calculated age-specific rates for 25-49 ('young'), 50-69 ('middle aged') and 70+ years ('older') and estimated the average annual percent of change in incidence and mortality trends 2000-2010 according to age group and sex, using joinpoint regression analysis. The incidence rates of MM across the region were uniformly increasing. Significant increases in mortality rates were observed in middle aged men in Serbia and Bulgaria, middle aged women in Slovenia, older men in the Czech Republic, Serbia and Turkey, and older women in Slovenia and Serbia. While MM incidence rates were still increasing across SEE, mortality trends diverged and were less favourable than in NWE. Empowering cancer registration a...Continue Reading

References

Jun 1, 1988·Archives of Dermatology·T B Fitzpatrick
Jan 29, 2000·Statistics in Medicine·H J KimD N Midthune
Apr 20, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E de VriesUNKNOWN EUROCARE working group
Dec 25, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sara GandiniCarmelo Francesco Melchi
Dec 25, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sara GandiniCarmelo Francesco Melchi
Aug 6, 2005·BMJ : British Medical Journal·H Gilbert WelchLisa M Schwartz
Aug 30, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sara GandiniCarmelo Francesco Melchi
Dec 26, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A MicheliUNKNOWN EUROCARE Working Group
Sep 29, 2011·Journal of the European Academy of Dermatology and Venereology : JEADV·R J T van der LeestV del Marmol
Apr 24, 2012·Croatian Medical Journal·Jelena Barbarić, Ariana Znaor
Apr 26, 2012·International Journal of Cancer. Journal International Du Cancer·Friederike ErdmannFreddie Bray
Jul 5, 2012·The British Journal of Dermatology·A M ForseaA C Geller
Dec 26, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ariana ZnaorJan W Willem Coebergh
Aug 8, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C BosettiC La Vecchia
Aug 22, 2013·Journal of the European Academy of Dermatology and Venereology : JEADV·M ArnoldE de Vries
Sep 24, 2013·Lancet·Alexander M M EggermontCaroline Robert
Nov 19, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Roberto ZanettiStefano Rosso
Dec 10, 2013·The Lancet Oncology·Roberta De AngelisUNKNOWN EUROCARE-5 Working Group
Feb 11, 2014·Journal of the National Cancer Institute·Klaus G GriewankRajmohan Murali
Mar 5, 2014·Nature Reviews. Clinical Oncology·Alexander M M Eggermont, Caroline Robert
Aug 19, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S SieslingJ W Coebergh
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Nov 18, 2014·The New England Journal of Medicine·Caroline RobertDirk Schadendorf
Feb 11, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dirk SchadendorfJedd D Wolchok
Mar 17, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Philippe AutierMathieu Boniol
Oct 1, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Emanuele CrocettiUNKNOWN EUROCARE-5 Working Group:
Nov 22, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Robert J T van der LeestLoes M Hollestein

❮ Previous
Next ❯

Citations

Mar 24, 2016·International Journal of Cancer. Journal International Du Cancer·Caroline Simberg-DanellHanna Eriksson
Jun 2, 2016·Health Education Research·S L ManneD A Kashy
Jul 30, 2016·The British Journal of Dermatology·A M ForseaG Argenziano
Jul 15, 2017·Journal of the European Academy of Dermatology and Venereology : JEADV·M AugustinR Kaufmann
Feb 28, 2019·Journal of the European Academy of Dermatology and Venereology : JEADV·D Skiljevic, L Sreckovic
Mar 15, 2019·Journal of the European Academy of Dermatology and Venereology : JEADV·E Gutiérrez-GonzálezB Pérez-Gómez
Nov 6, 2018·Journal of the European Academy of Dermatology and Venereology : JEADV·C GarbeU Leiter
Nov 7, 2018·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Eszter A JankaGabriella Emri
Sep 16, 2017·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Ofelia ŞuteuDaniela Coza
Aug 20, 2020·Ophthalmic Epidemiology·Zornitsa Ivanova Zlatarova, Klara Georgieva Dokova
May 26, 2018·International Journal of Molecular Sciences·Dorina CoricovacOvidiu Boruga
May 15, 2018·The British Journal of Dermatology·A CayuelaM Rodríguez de la Borbolla
Nov 28, 2018·Melanoma Research·Fortunato BianconiFabrizio Stracci
Oct 12, 2018·Revista da Escola de Enfermagem da U S P·İlknur Göl, Özüm Erkin
May 9, 2019·Ciência & saúde coletiva·Camila Alves Dos Santos, Dyego Leandro Bezerra Souza
Sep 9, 2016·South Asian Journal of Cancer·Sudeep Gupta
Oct 9, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·A J Durán-RomeroJ J Pereyra-Rodriguez
Mar 7, 2020·The British Journal of Dermatology·D D YangJ Shalhoub
Dec 7, 2020·Anais Brasileiros De Dermatologia·Rodrigo Vasconi Sáez BrownDaniel Holthausen Nunes
Dec 15, 2020·European Journal of Medicinal Chemistry·Cindy PatinotePierre-Antoine Bonnet
Feb 12, 2021·International Journal of Dermatology·Fernando García-SoutoJose-Juan Pereyra-Rodríguez
Jan 7, 2021·International Journal of Cancer. Journal International Du Cancer·Lauro BucchiFabio Falcini
Oct 15, 2021·Journal of Racial and Ethnic Health Disparities·Jesus C FabregasJeannine M Brant

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.